NeuroDerm Ltd. Announces Presentation of ND0612 Phase 1 and Phase 2 Results at the 2013 International Congress of Parkinson's Disease and Movement Disorders
6/13/2013 6:37:07 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NESS ZIONA, Israel, June 13, 2013 /PRNewswire/ --
NeuroDerm, Ltd. today announced that abstracts reporting results from a phase I study in healthy volunteers, and preliminary results from a phase IIA study in advanced Parkinson's patients, of ND0612, have been selected for presentation at the 17th International Congress of Parkinson's Disease and Movement Disorders, June 16th-20th in Sydney, Australia.
Help employers find you! Check out all the jobs and post your resume.